Publishing research using ab63535? Please let us know so that we can cite the reference in this datasheet.
ab63535 has been referenced in 1 publication.
Zhang X et al.Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.J Hematol Oncol 10:29 (2017).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up